13F Data
13F filer · CIK 1791827

Avidity Partners Management LP

DALLAS, TX · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$624.4M
$-311.3M vs prior
Positions
45
New / sold out
9 / 16
Added / reduced
4 / 27
Turnover
7.0%
buys $54.4M · sells $490.6M
Top-10 weight
81.9%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewMOBIA MED INC+798,282–+$10.7M
NewIMMUNIC INC+669,941–+$10.3M
NewSENSEONICS HLDGS INC+1,600,000–+$9.1M
AddedCG ONCOLOGY INC+110,000+8.5%+$7.8M
NewNUVECTIS PHARMA INC+200,000–+$3.7M
NewALAMAR BIOSCIENCES INC+110,000–+$3.0M
AddedINSULET CORP+14,000+140.0%+$2.1M
NewAVALYN PHARMACEUTICALS INC+60,000–+$2.0M
NewKAILERA THERAPEUTICS INC+80,000–+$1.8M
AddedSTRUCTURE THERAPEUTICS INC+20,000+25.6%+$1.1M
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedDIANTHUS THERAPEUTICS INC-2,104,184-50.0%$-205.1M
ReducedORUKA THERAPEUTICS INC-760,424-50.0%$-72.4M
ReducedJADE BIOSCIENCES INC-1,100,708-39.3%$-24.5M
ReducedPERSPECTIVE THERAPEUTICS INC-5,799,999-47.9%$-19.8M
ReducedTEVA PHARMACEUTICAL INDS LTD-450,100-69.2%$-15.2M
ReducedAKTIS ONCOLOGY INC-452,932-48.3%$-14.6M
Sold outIMMUNIC INC-7,369,352-100.0%$-13.9M
ReducedENLIVEN THERAPEUTICS INC-250,000-31.3%$-12.7M
ReducedVIR BIOTECHNOLOGY INC-1,050,000-66.9%$-10.7M
ReducedPALVELLA THERAPEUTICS INC NE-70,000-50.0%$-10.7M
33 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $158.7MQ1 2020: $723.6MQ2 2020: $1.6BQ3 2020: $2.2BQ4 2020: $3.1BQ1 2021: $3.6BQ2 2021: $3.7BQ3 2021: $4.5BQ4 2021: $4.7BQ1 2022: $4.8BQ2 2022: $4.4BQ3 2022: $4.9BQ4 2022: $4.6BQ1 2023: $3.0BQ2 2023: $2.9BQ3 2023: $2.5BQ4 2023: $2.7BQ1 2024: $3.1BQ2 2024: $2.4BQ3 2024: $2.0BQ4 2024: $1.0BQ1 2025: $524.7MQ2 2025: $502.0MQ3 2025: $439.4MQ4 2025: $346.7MQ1 2026: $935.7MQ2 2026: $624.4M
Q4 2019Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1DIANTHUS THERAPEUTICS INCCOM2,104,184$205.1M32.85%
2CG ONCOLOGY INCCOM1,398,948$99.4M15.92%
3ORUKA THERAPEUTICS INCCOM760,424$72.4M11.59%
4JADE BIOSCIENCES INCCOM NEW1,700,708$37.8M6.05%
5ENLIVEN THERAPEUTICS INCCOM550,000$27.9M4.47%
6PERSPECTIVE THERAPEUTICS INCCOM NEW6,299,999$21.5M3.44%
7AKTIS ONCOLOGY INCCOM484,200$15.6M2.50%
8PALVELLA THERAPEUTICS INC NECOM70,000$10.7M1.71%
9MOBIA MED INCCOMMON STOCK798,282$10.7M1.71%
10REPLIGEN CORPCOM77,800$10.6M1.70%
35 more rows. Subscribe for $29/month to see every row, download the data and use the API.